Today

Agents

Chat

Arena

Discover

More

App

Insmed launches Brinsupri 25 mg tablets in Japan for bronchiectasis - INSM News | Rallies

Insmed launches Brinsupri 25 mg tablets in Japan for bronchiectasis

INSM•2026-10-19

Insmed launched Brinsupri 25 mg tablets in Japan to treat non-cystic fibrosis bronchiectasis.

1. Japan launch

Insmed launched Brinsupri 25 mg tablets, containing brensocatib hydrate, in Japan for the treatment of non-cystic fibrosis bronchiectasis.

Related News

dLocal study finds local payment methods boost merchant transaction volume up to 55%

DLO•2026-10-19

Hepion receives FDA support for planned Phase 2 trial of GV104 in gambling disorder

HEPA•2026-10-19

TransCode Therapeutics to present TTX-MC138 Phase 1a trial data at ESMO 2026

RNAZ

•

2026-10-19

Altimmune's pemvidutide reduces liver fibrosis markers in Phase 2b MASH trial

ALT•2026-10-19

Axcelis Technologies target price cut to $165 from $198

ACLS•2026-10-19